Evidence map›Paper›PMID 41458939›Full record

ReviewNeuro-oncology practice2025

Opportunities and challenges in application of VASARI features in neuro-oncology.

Maria Golebiowska, Sun Mo Nam, Jong Ha Hwang, Soon-Tae Lee, Seung Hong Choi, Chul-Kee Park

Abstract readReview
In one paragraph

Review in Neuro-oncology practice, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Maria GolebiowskaDepartment of Neurosurgery, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Republic of Korea.
Sun Mo NamDepartment of Neurosurgery, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Republic of Korea.
Jong Ha HwangDepartment of Neurosurgery, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Republic of Korea.
Soon-Tae LeeDepartment of Neurology, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Republic of Korea.ORCID https://orcid.org/0000-0003-4767-7564
Seung Hong ChoiDepartment of Radiology, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Republic of Korea.
Chul-Kee ParkDepartment of Neurosurgery, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Republic of Korea.ORCID https://orcid.org/0000-0002-2350-9876

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The application of objective radiological data in glioma research remains an underexplored opportunity in neuro-oncology. Despite multiple efforts to incorporate radiomic features in glioma analysis, the lack of a unified imaging reporting system in gliomas prevents large-scale, multi-center scientific collaborations from integrating comparable imaging variables to their work. VASARI lexicon, a set of 30 semantic radiomic features using controlled vocabulary and visual guides, was created to become a shared language for neuroscientists evaluating gliomas. It has been proven, that VASARI features are not only reliably correlated with various genetic aberrations but are also increasingly included in numerous statistical and machine learning models for predicting overall survival, tumor recurrence, glioma grade, and tumor molecular characteristics. In this review, we present an overview of VASARI application in prediction modeling, including the best-performing models and relevance of VASARI features depending on the predicted outcomes. We delve into the opportunities related to the inclusion of VASARI along with clinical, computational radiomic, and multi-omic features to construct combined neuro-oncological prediction models. Lastly, we discuss the challenges and limitations of currently performed models as well as the methods to overcome them using automatic feature extraction solutions.

Indexed as

diagnostic imagingGliomaprediction modelradiomicsVASARI features

Identifiers

PMID41458939
PMCPMC12741836

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.